Clinical Trial Update: An Evaluation of Weekly Tafenoquine [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated weekly tafenoquine for falciparum parasitaemia (malaria) with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• Tafenoquine (tafenoquine)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Falciparum Parasitaemia | Phase 2 | Status: COMPLETED | Results posted: 2017-02-24